Amyes S G
Antimicrob Agents Chemother. 1982 Feb;21(2):288-93. doi: 10.1128/AAC.21.2.288.
The combined effects of trimethoprim and sulfamethoxazole on the viability of Escherichia coli K-12 and resistant strains possessing resistance plasmids were examined in minimal medium. When methionine, glycine, and adenine were present, sulfamethoxazole could enhance trimethoprim activity against E. coli K-12 so that the combination was bactericidal. However, this enhancement occurred over a narrow range of trimethoprim concentrations (0.04 to 0.2 mg liter-1) and only when the sulfamethoxazole concentration was more than 10 times that of trimethoprim. Under certain conditions, sulfamethoxazole enhanced trimethoprim bactericidal activity against E. coli K-12 carrying plasmid R1 at concentrations of sulfamethoxazole far below those required to inhibit the organism, but there was no such enhancement with the same host containing the SSu plasmid. Similar differences were found with strains possessing trimethoprim resistance plasmids R483 and R751. Sulfamethoxazole can promote a bactericidal response with trimethoprim in E. coli K-12 and some of its resistant derivatives, but only under a narrow range of concentrations.
在基本培养基中检测了甲氧苄啶和磺胺甲恶唑联合作用对大肠杆菌K-12以及携带耐药质粒的耐药菌株生存能力的影响。当存在蛋氨酸、甘氨酸和腺嘌呤时,磺胺甲恶唑可增强甲氧苄啶对大肠杆菌K-12的活性,使得联合用药具有杀菌作用。然而,这种增强作用仅在甲氧苄啶浓度的狭窄范围内(0.04至0.2毫克/升)出现,且仅当磺胺甲恶唑浓度超过甲氧苄啶浓度10倍以上时才会发生。在某些条件下,磺胺甲恶唑在远低于抑制该菌所需浓度时,就能增强甲氧苄啶对携带质粒R1的大肠杆菌K-12的杀菌活性,但对于含有SSu质粒的同一宿主菌则没有这种增强作用。对于携带甲氧苄啶耐药质粒R483和R751的菌株也发现了类似差异。磺胺甲恶唑可与甲氧苄啶共同促使大肠杆菌K-12及其一些耐药衍生物产生杀菌反应,但仅在狭窄的浓度范围内有效。